Skip to main content

Find Clinical Trials

Home
Conditions
Graft Versus Host Disease

Clinical trial condition

Graft Versus Host Disease

Explore clinical trials studying Graft Versus Host Disease. Study availability and eligibility vary by location and protocol.

129 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Graft Versus Host Disease trial results

Completed

Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease

NCT01795573

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: H Lee Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

NCT00053157

Conditions: Bone Marrow Diseases, Burkitt Lymphoma, Chronic Disease, +55 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

NCT00366145

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Arizona Cancer Center Tucson, Arizona, United States

City of Hope Duarte, California, United States

Univeristy of California San Francisco San Francisco, California, United States

View all 70 locations

View Trial Details

Completed

Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD)

NCT00562497

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: University of Alabama Birmingham (UAB) Hospital Birmingham, Alabama, United States

UCLA Medical Center Los Angeles, California, United States

University of California Medical Center San Francisco, California, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

View all 53 locations

View Trial Details

Completed

Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease

NCT00074035

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States

CCOP - Christiana Care Health Services Newark, Delaware, United States

University of Illinois Cancer Center Chicago, Illinois, United States

University of Chicago Cancer Research Center Chicago, Illinois, United States

View all 16 locations

View Trial Details

Completed

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

NCT01911039

Conditions: Allogeneic Hematopoietic Cell Transplant Recipient, Graft Versus Host Disease, Graft vs Host Disease, +1 more
Locations: Stanford University, School of Medicine Palo Alto, California, United States

View Trial Details

Completed

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

NCT02588339

Conditions: GVHD, Graft Versus Host Disease, Graft vs Host Disease, +3 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

NCT02144701

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

NCT01857336

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases, +2 more
Locations: Peking University Institute of Hematology Beijing, Beijing Municipality, China

View Trial Details